Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2022

Lexaria Bioscience Corp. (NASDAQ: LEXX), Growing its Market Share, One Patent at a Time

Posted on September 16, 2022 by MissionIR

Lexaria’s development of its patented DehydraTECH(TM) technology since 2014 has yielded 27 patents in Australia, the United States, the European Union, Japan, India and Mexico with approximately 50 additional patents pending around the world Its latest patent, granted in Mexico, … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

Research from D-Wave Quantum Inc. (NYSE: QBTS) Demonstrates Large-Scale Coherent Quantum Annealing

Posted on September 16, 2022 by MissionIR

D-Wave has announced first ever demonstration of large-scale coherence in quantum annealers New research findings open the door to simulations of exotic phases of matter (unusual states of matter, outside of liquid, solid or gas, that make up the universe)  … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Secures Expanded Contract with Oregon-Based Client

Posted on September 15, 2022 by MissionIR

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced that a locally owned, Oregon-based healthcare system has expanded its contract for its many facilities in the state. The announcement reads, “On … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Hypertension Treatment Program Stands Distinct

Posted on September 15, 2022 by MissionIR

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently provided information to its stakeholders to help them conveniently research and understand different non-affiliated third-party sources and their methodologies for valuing biotech and pharmaceutical companies. The information includes a discussion of underlying logic-based evaluations … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Provides First Look at Its Ultra-High-Performance FIVE RS

Posted on September 15, 2022 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced specifications and unveiled details on the FIVE RS – its ultra-high-performance EV sport crossover. The Mullen FIVE RS will be equipped with 800-volt architecture, all-wheel drive, a two-speed … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Participation in H.C. Wainwright Global Investment Conference

Posted on September 15, 2022 by MissionIR

Freight Technologies (NASDAQ: FRGT), a technology company developing solutions to optimize and automate the supply chain process as well as providing a platform for business-to-business (“B2B”) cross-border shipping in the United States/Mexico/Canada (“USMC”) region, will be presenting today at the … Continue reading →

Posted in Freight Technologies Inc. FRGT | Leave a comment

MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Uplists to OTCQX Market Exchange

Posted on September 15, 2022 by MissionIR

EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, announced an important milestone for the company: its common shares began trading on the OTCQX(R) Best Market in the United States. The shares are trading under the … Continue reading →

Posted in EverGen Infrastructure Corp. EVGIF | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Marking Industry’s First-Ever Entry of Novel Psilocybin Analog into Clinical Development

Posted on September 14, 2022 by MissionIR

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, is making significant headway with its flagship deuterated psilocybin analog, CYB003. “CYB003 has the potential to effectively treat … Continue reading →

Posted in Cybin Inc. CYBN | Leave a comment

MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Closes $6M Private Placement Agreement

Posted on September 14, 2022 by MissionIR

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, has closed on a private placement agreement with two healthcare-focused institutional investors. The agreement consisted of the issue and sale of 691,245 of INM common … Continue reading →

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment

FingerMotion Inc. (NASDAQ: FNGR) Upgrades to Sapientus Analytics Division Hone in on Tech Tool Trends in China

Posted on September 14, 2022 by MissionIR

FingerMotion is an Nasdaq-traded company making inroads among China’s huge tech-hungry population with mobile services and big data analytics for commercial operations FingerMotion recently announced upgrades to its Sapientus division, which is currently focused on providing the insurance industry with … Continue reading →

Posted in FingerMotion Inc. FNGR | Leave a comment